The life sciences industry is undergoing a fundamental change in their business model. Shift from blockbuster drug model to precision medicine and specialty drugs has disrupted the life sciences ecosystem. Traditionally, drug discovery cycles took three to six years. However, changed market dynamics demand that enterprises accelerate this cycle and bring it down to three to nine months. Therefore, life sciences enterprises are experimenting with innovative drug discovery models to tackle this situation.
Clinical trials form a key part of this overall transformation. Trial sponsors, that earlier relied on Contract Research Organization (CRO) and technology service providers, are moving to SaaS-based trial platforms. These platforms are not only agile and nimble, but also user-friendly and flexible. Everest Group’s HLS IT research program realizes the change in the market situation and has come up with a research report that addresses this particular need.
In this report, we analyze the capabilities of 11 product vendors specific to the life sciences clinical trials products industry. These vendors are mapped on the Everest Group PEAK Matrix™, which is a composite index of a range of distinct metrics related to a provider’s capability and market impact.
This report is structured across four key sections:
- Introduction and overview
- Market trends in clinical trials
- PEAK Matrix for clinical trials products
- Profiles of clinical trials product vendors
Players assessed: Accenture, BioClinica, Cognizant, DATATRAK, DSG, ERT Systems, Medidata, MedNet Solutions, Oracle, PAREXEL Informatics, and Veeva Systems
Everest Group has a complimentary four-page PEAK Matrix preview document for this service provider landscape report.
Membership(s)
Healthcare & Life Sciences IT Outsourcing
